Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE BE READY NOW Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base Education EPI-Net EPOXI Interview Mpox NeoDeco NOFLU Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PrIMAVeRA PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid STRIDE-CAP Training Vaccines 8.04.2024 RECOVERY trial activated in France, first patient enrolled Influenza trial expands in Europe with Angers University Hospital Center site activation 3.04.2024 First patients enrolled in POS-Disease X First patient enrolled at the Erasmus Medical Center in the Netherlands 20.03.2024 Join us at ECCMID 2024 Our team is looking forward to welcoming you at booth E81 from 27-30 April. 19.03.2024 Ecraid brings together Dutch investigators to foster collaboration Investigators from across the Netherlands got together in Utrecht to form closer ties and learn more about Ecraid's projects. 5.03.2024 Young Investigator Workshop returns to ECCMID in 2024 Young investigators working on Ecraid studies will share valuable advice and lessons learned. 29.02.2024 Ecraid network responds to hypervirulent Klebsiella pneumoniae warning The POS-cUTI and POS-VAP study teams swiftly analysed their data to quantify the prevalence of the dangerous bacterium. Load More
8.04.2024 RECOVERY trial activated in France, first patient enrolled Influenza trial expands in Europe with Angers University Hospital Center site activation
3.04.2024 First patients enrolled in POS-Disease X First patient enrolled at the Erasmus Medical Center in the Netherlands
20.03.2024 Join us at ECCMID 2024 Our team is looking forward to welcoming you at booth E81 from 27-30 April.
19.03.2024 Ecraid brings together Dutch investigators to foster collaboration Investigators from across the Netherlands got together in Utrecht to form closer ties and learn more about Ecraid's projects.
5.03.2024 Young Investigator Workshop returns to ECCMID in 2024 Young investigators working on Ecraid studies will share valuable advice and lessons learned.
29.02.2024 Ecraid network responds to hypervirulent Klebsiella pneumoniae warning The POS-cUTI and POS-VAP study teams swiftly analysed their data to quantify the prevalence of the dangerous bacterium.